TrialDiabetologia2025

Sex differences in the efficacy of angiotensin receptor blockers on kidney and cardiovascular outcomes among individuals with type 2 diabetes and diabetic kidney disease: post hoc analyses of the RENAAL and IDNT trials.

Sieta T de Vries et al.PubMed ↗Publisher ↗

No numbers read from the abstract.